Video

Q&A with Mitchell Smith: The Merits of Ten Year Followup

Author(s):

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

Mitchell Smith, MD, Cleveland Clinic shared highlights of his team's posters and discussed the progression of immunotherapies at the 57th American Society of Hematology Annual Meeting.

According to Smith, "While response rates aren't as high as we like, and they're not durable in everyone, you can see on the horizon advances in the cell technology and in patient selection."

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.